Kaplan-Meier analysis of investigator-assessed PFS according to cell of origin for patients with and without PET CR by standard Lugano 2014 criteria (PET ITT population, n = 1092). According to standard Lugano 2014 response criteria, no PET CR includes PR, nonresponse, and progressive disease patients with no progressive disease event by the primary end point definition (investigator-assessed PFS). P values by log-rank test.